Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1412063.RAs2v235ngODdDrQdpedko5pYIUm0wRCp5ZlMHMBjLD9E130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1412063.RAs2v235ngODdDrQdpedko5pYIUm0wRCp5ZlMHMBjLD9E130_assertion type Assertion NP1412063.RAs2v235ngODdDrQdpedko5pYIUm0wRCp5ZlMHMBjLD9E130_head.
- NP1412063.RAs2v235ngODdDrQdpedko5pYIUm0wRCp5ZlMHMBjLD9E130_assertion description "[In contrast to rare mutations in stomach adenocarcinomas, a high frequency of CDKN2 mutations was identified in other 3 cancers, 11 of 20 (55%) lung cancers (7 of 10 NSCLCs and 4 of 10 SCLCs), 14 of 20 (70%) cervix cancers and 11 of 20 (55%) hepatocellular carcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1412063.RAs2v235ngODdDrQdpedko5pYIUm0wRCp5ZlMHMBjLD9E130_provenance.
- NP1412063.RAs2v235ngODdDrQdpedko5pYIUm0wRCp5ZlMHMBjLD9E130_assertion evidence source_evidence_literature NP1412063.RAs2v235ngODdDrQdpedko5pYIUm0wRCp5ZlMHMBjLD9E130_provenance.
- NP1412063.RAs2v235ngODdDrQdpedko5pYIUm0wRCp5ZlMHMBjLD9E130_assertion SIO_000772 9873831 NP1412063.RAs2v235ngODdDrQdpedko5pYIUm0wRCp5ZlMHMBjLD9E130_provenance.
- NP1412063.RAs2v235ngODdDrQdpedko5pYIUm0wRCp5ZlMHMBjLD9E130_assertion wasDerivedFrom befree-2016 NP1412063.RAs2v235ngODdDrQdpedko5pYIUm0wRCp5ZlMHMBjLD9E130_provenance.
- NP1412063.RAs2v235ngODdDrQdpedko5pYIUm0wRCp5ZlMHMBjLD9E130_assertion wasGeneratedBy ECO_0000203 NP1412063.RAs2v235ngODdDrQdpedko5pYIUm0wRCp5ZlMHMBjLD9E130_provenance.